• Nie Znaleziono Wyników

The Voice of the Editor-in-Chief

N/A
N/A
Protected

Academic year: 2022

Share "The Voice of the Editor-in-Chief"

Copied!
2
0
0

Pełen tekst

(1)

1

The Voice of the Editor-in-Chief

The end of the year makes us reflect on all aspects of everyday life and review accomplishments and les- sons learned. First, I would like to thank you for the active participation in creating “Clinical Diabetology”

by submitting many interesting papers. Thanks to your efforts, our journal is indexed in the Scopus database and currently also in the Web of Science, which is an important starting point for its further development.

Moreover, “Clinical Diabetology” includes more and more original and review articles sent by foreign authors, which significantly broadens our view on diabetes care and improves the rank of our journal.

Offering you the last issue of “Clinical Diabeto- logy” in 2018, I would like to draw your attention to an article referring to diabetes care for children and adolescents in Poland. The authors point to significant

differences in the frequency, causes and duration of hospitalization of children with diabetes in different regions of Poland, which implies the need to ensure uniform access to specialist medical care as well as to increase public awareness about diabetes symp- toms in order to avoid hospitalization related with ketoacidosis in patients with newly diagnosed type 1 diabetes. Moreover, it is worth paying attention to the case report discussing iatrogenic hypoglycemia, which significantly widens the standard perception of this phenomenon, as well as an article about new developments in the pharmaceutical industry presen- ting new rapid-acting insulin analog.

I wish you a happy New Year 2019 and encourage you for further cooperation in creating “Clinical Dia- betology”

Editor-in-Chief

Prof. Janusz Gumprecht

Dear Colleagues,

(2)

Cytaty

Powiązane dokumenty

At the beginning of October, annual meeting of European Association for the Study of Diabetes (EASD) will be held in Berlin, and one of the most awaited events during this

Among papers included in this issue of “Clinical Diabetology”, it is worth paying attention to a multi- centre study conducted in 2013–2017 in women with type 1 diabetes who,

As the practical management of patients with diabetes should be based primarily on knowledge derived from Evidence Based Medicine (EBM), the reference to the EBM

I would like to draw your attention to the problem of diabetes care quality discussed by researchers from Libya, an interesting case report of the use of hydroxychloroquine in type

Many interesting reports presented during the Congress addressed, among others, epidemiology, new possibilities of molecular biology, measurable effects of translating basic

Following the publication of the results of already completed Cardiovascular Outcome Trials (CVOTs) on new molecules used in the treatment of diabetes, there is no doubt that

In the InTandem3 study (Study to Evaluate the Safety of So- tagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycaemic Control With Insulin Therapy Alone) with

In addition to attending the scientific meetings, I also encourage you to read the latest issue of the “Clinical Diabetology”, where, among a number of interesting articles, I would